Literature DB >> 17116501

Dyspareunia.

Colin MacNeill1.   

Abstract

Dyspareunia, better termed women's sexual pain, is a poorly understood disorder once believed to be purely psychologic. Thanks to cooperative research efforts from several specialties toward defining subsets of the disorder, understanding the etiology of subsets and their comorbidities and new concepts for diagnosis and management are being validated or are being put into practice. This review describes the surprising prevalence of sexual pain, outlines new definitions for subtypes of sexual pain and diagnostic criteria for them, and applies these diagnoses to the task of selecting treatment options.

Entities:  

Mesh:

Year:  2006        PMID: 17116501     DOI: 10.1016/j.ogc.2006.09.003

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  5 in total

1.  Dyspareunia in Puerto Rican middle-aged women.

Authors:  Yaniris R Avellanet; Ana Patricia Ortiz; José R Pando; Josefina Romaguera
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

2.  Self-reported vulvar pain characteristics and their association with clinically confirmed vestibulodynia.

Authors:  Bernard L Harlow; Gabriela Vazquez; Richard F MacLehose; Darin J Erickson; J Michael Oakes; Susan J Duval
Journal:  J Womens Health (Larchmt)       Date:  2009-09       Impact factor: 2.681

3.  Successful Treatment of Dyspareunia with an Integrative Medicine Approach: A Case Report.

Authors:  Brenda Arthur; Myung Kyu Chung; Tracy Brobyn; Patrick J LaRiccia
Journal:  Integr Med (Encinitas)       Date:  2019-12

4.  The relationship between fibromyalgia and pressure pain threshold in patients with dyspareunia.

Authors:  Hasan Terzi; Rabia Terzi; Ahmet Kale
Journal:  Pain Res Manag       Date:  2015 May-Jun       Impact factor: 3.037

Review 5.  Evaluation and Treatment of Female Sexual Pain: A Clinical Review.

Authors:  James Sorensen; Katherine E Bautista; Georgine Lamvu; Jessica Feranec
Journal:  Cureus       Date:  2018-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.